AI MARKET SCANNING

Tscan Therapeutics Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +1.18%
MAX GAP RECORD +25.29%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $TCRX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 19, 2026 Earnings Release 2026-08-19 (BEFORE OPEN)
-6.67%
May 06, 2026 Earnings Release 2026-05-06 (BEFORE OPEN)
-1.65%
Mar 04, 2026 Earnings Release 2026-03-04 (AFTER CLOSE)
+3.70%
Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN)
+0.00%
Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE)
+4.19%
May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN)
-2.00%
Mar 05, 2025 Earnings Release 2025-03-05 (AFTER CLOSE)
-3.65%
Nov 12, 2024 Earnings Release 2024-11-12 (UNDETERMINED)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 6.2%
Bullish Gaps (3)
Bearish Gaps (6)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $TCRX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions to enable the development of efficacious TCR-Ts. The company was founded by Christoph H….

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗